Contact Lenses with Medicament Coating for Drug Release in Glaucoma Treatment
Summary
MEDIPRINT OPHTHALMICS INC. filed patent application US20260090984A1 for contact lenses incorporating medicament coatings for controlled drug release, specifically targeting glaucoma treatment through sustained delivery of drugs such as bimatoprost. The application covers the lens composition including N-vinylpyrrolidone, soaking solutions, and methods for loading and refreshing drug-eluting contact lenses. This patent application (No. 19411056, filed December 5, 2025) names six inventors including Praful Doshi and Brandon Huang.
What changed
The patent application discloses contact lenses with at least one coating layer providing drug storage and controlled release for treating diseases including glaucoma. The invention covers the lens composition containing bimatoprost and N-vinylpyrrolidone, packaged medical devices with medicaments, drug delivery contact lenses, soaking solutions for loading lenses, and methods for making and using loaded and refreshed contact lenses. The technology enables slow release of glaucoma-treating drugs and comfort-enhancing drugs.
Medical device manufacturers, pharmaceutical companies, and researchers in ocular drug delivery should review this patent application to understand the competitive landscape for drug-eluting contact lens technology. Healthcare providers offering glaucoma treatment may find this relevant for understanding emerging therapeutic delivery methods. No immediate compliance action is required as this is a patent filing rather than an enforceable regulation.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
CONTACT LENSES INCLUDING MEDICAMENTS AND METHODS OF MAKING AND USING SAME INCLUDING SLOW RELEASE OF GLAUCOMA TREATING DRUGS AND COMFORT ENHANCING DRUGS
Application US20260090984A1 Kind: A1 Apr 02, 2026
Assignee
MEDIPRINT OPHTHALMICS INC.
Inventors
Praful DOSHI, Brandon HUANG, Stephen HABE, Neil PATODIA, Pavanasam BALASUBRAMANIAN, Tyler HOUCHIN
Abstract
The present invention recognizes that medical devices, such as contact lenses, can be made having at least one coating layer provide drug storage and drug release for the treatment of various diseases, disorders, or conditions. One aspect includes a packaged medical device including a medicament. Another aspect includes a drug delivery contact lens. A further aspect includes a method of making a drug delivery contact lens. An additional aspect includes a method of using a drug delivery contact lens. A further aspect includes a medical device including bimatoprost and N-vinylpyrrolidone. An additional aspect includes a contact lens soaking solution. Another aspect includes a method of loading contact lenses. Another aspect includes loaded and refreshed contact lenses. A further aspect includes methods of using loaded and refreshed contact lenses.
CPC Classifications
A61K 9/0051 A61K 31/46 A61K 31/5575 A61K 31/728 A61K 38/179 A61K 47/10
Filing Date
2025-12-05
Application No.
19411056
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.